← FDA DRUG APPROVALS

FDA ANDA · ANDA040190

PHENTERMINE HYDROCHLORIDE

Sponsor: ELITE LABS INC

APPLICATION
ANDA040190
TYPE
ANDA
ORIGINAL APPROVAL
1997-05-30
LATEST ACTION
2017-05-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PHENTERMINE HYDROCHLORIDEPrescription
PHENTERMINE HYDROCHLORIDE 37.5MG · TABLET · ORAL

Approval history

2017-05-31Labeling · Supplement 17 · standardAP
2013-11-08Manufacturing (CMC) · Supplement 15AP
2002-11-14Manufacturing (CMC) · Supplement 4AP
1999-09-02Manufacturing (CMC) · Supplement 3AP
1999-05-07Labeling · Supplement 2AP
1998-08-10Labeling · Supplement 1AP
1997-05-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →